CLEW (previously known as Intensix) CEO Gal Salomon will be a featured speaker at the MIXiii BIOMED 2017 Conference at the David InterContinental, Tel Aviv, on May 24, 2017. His presentation, entitled Predictive Critical Care, will address the use of Big Data analytics for the early detection of life threatening patient deterioration in the ICU and high acuity departments. In addition, Gal will share the lessons learned in previous startups and in the venture capital industry, and explain how they are being applied today.
Gal is one of Israel’s best known serial entrepreneurs, having repeatedly shepherded technology from the concept phase to mass deployment, and successfully guided companies from the seed stage through M&A with large multi-nationals. He is the founder of Sansa Security (formerly Discretix), where he served as CEO until he joined Pitango Venture Capital as a Venture Partner. During this time, he also continued as the active Chairman at Discretix, until it was acquired by ARM in 2015. Prior to founding Discretix, he served in multiple positions at DSP Communications and at Intel.
The MIXiii BIOMED 2017 Conference aims to fuel the innovations and trends that are shaping the future of healthcare systems and life science. This year’s conference will focus on dynamic areas in healthcare today, such as personalized medicine, neurodegenerative diseases, robotics, genetics and epigenetics for longevity, and the impact of aging on population health and the world economy, among other important topics.